Clover Health Investments Operating Income 2020-2024 | CLOV

Clover Health Investments operating income from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Clover Health Investments Annual Operating Income
(Millions of US $)
2023 $-209
2022 $-372
2021 $-637
2020 $-93
2019 $-183
Clover Health Investments Quarterly Operating Income
(Millions of US $)
2024-03-31 $-23
2023-12-31 $-59
2023-09-30 $-41
2023-06-30 $-29
2023-03-31 $-80
2022-12-31 $-107
2022-09-30 $-74
2022-06-30 $-103
2022-03-31 $-87
2021-12-31 $-187
2021-09-30 $-149
2021-06-30 $-182
2021-03-31 $-119
2020-12-31 $-68
2020-09-30 $-22
2020-06-30 $23
2020-03-31 $-27
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.431B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.024B 20.33
Inspire Medical Systems (INSP) United States $4.855B 0.00
Axonics (AXNX) United States $3.435B 0.00
IRhythm Technologies (IRTC) United States $3.072B 0.00
10x Genomics (TXG) United States $3.022B 0.00
Azenta (AZTA) United States $3.015B 163.85
Olink Holding AB (publ) (OLK) Sweden $2.918B 0.00
Enovis (ENOV) United States $2.779B 20.60
Hims & Hers Health (HIMS) United States $2.603B 0.00
Privia Health (PRVA) United States $2.238B 99.26
Schrodinger (SDGR) United States $1.679B 0.00
Omnicell (OMCL) United States $1.376B 47.56
Phreesia (PHR) United States $1.237B 0.00
Standard BioTools (LAB) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.636B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Talkspace (TALK) United States $0.451B 0.00
Health Catalyst (HCAT) United States $0.393B 0.00
Pulmonx (LUNG) United States $0.342B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.300B 0.00
P3 Health Partners (PIII) United States $0.236B 0.00
Outset Medical (OM) United States $0.214B 0.00
Butterfly Network (BFLY) United States $0.201B 0.00
American Well (AMWL) United States $0.150B 0.00
Augmedix (AUGX) United States $0.128B 0.00
TruBridge (TBRG) United States $0.121B 5.17
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.094B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.049B 0.00
Movano (MOVE) United States $0.039B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.017B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.012B 0.00
Biotricity (BTCY) United States $0.011B 0.00
ETAO (ETAO) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00